TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. By Cancer History Project January 14, 2005
TCL Archive Also in This 8-page Issue: NCI Seeks $6.17 Billion in “Bypass” Budget Request, But Faces Shortfall In Its Actual Budget. By Cancer History Project January 14, 2005
TCL Archive NCI Names 15 to Director’s Consumer Liaison Group. By Cancer History Project January 14, 2005
TCL Archive SAIC-Frederick Makes Awards To Proteomics Research Teams. By Cancer History Project January 14, 2005
Article “Backwater to Blockbuster” co-authors Chuck Sherr and Bill Evans on collaborating to write the untold story of the explosive growth of St. Jude Children’s Research Hospital By Cancer History Project
Article Bernie Lewinsky on radiation oncology giants, fifty years of progress, and the healing power of art By Cancer History Project
